AstraZeneca Lupus Drug Fails to Meet Main Goal in Study AstraZeneca Lupus Drug Fails to Meet Main Goal in Study

AstraZeneca ' s experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news